A comprehensive view of Medicare. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

CMS announces all manufacturers of the 10 drugs selected for the Medicare Drug Price Negotiation Program have agreed to participate in the program; negotiated prices to be effective beginning in 2026

Elevance Health to offer flexible and simplified Medicare Advantage Plans to nearly 93% of Medicare-eligible individuals through a 91-county expansion in 2024; Elevance aims to increase revenue by 6.2% in 2023

UnitedHealth Group plans to expand coverage to reach 96% of Medicare customers by 2024; UNH aims to add 700,000 customers to its Medicare Advantage plan in 110 new counties, and 2.7 million customers to its Chronic Needs Plans

AstraZeneca, Bristol Myers Squibb, and Merck to participate in the first round of drug price negotiations under the Inflation Reduction Act; J&J, Novartis, Lilly, Novo Nordisk, and Amgen yet to declare their stance

Kaiser reports its private and Medicare plans are highest-rated among competitor's plans, or tied for highest, in every region it serves in 2023 National Committee for Quality Assurance’s annual report

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count